LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3699 | 3486 | 1.0612 | 1.0815 |
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3571 | 3486 | 1.0245 | 1.0326 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 868 | 2916 | 3486 | 0.8366 | 0.7824 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 868 | 1578 | 3486 | 0.4527 | 0.2713 |
MDA-MB-231 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3040 | 3486 | 0.8722 | 0.8298 |
MDA-MB-231 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 868 | 2574 | 3486 | 0.7383 | 0.6515 |
MDA-MB-231 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 868 | 2837 | 3486 | 0.8139 | 0.7522 |
MDA-MB-231 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2640 | 3486 | 0.7574 | 0.6770 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 3686 | 3486 | 1.0573 | 1.0764 |
MDA-MB-231 | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 868 | 2466 | 3486 | 0.7073 | 0.6103 |
MDA-MB-231 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2730 | 3486 | 0.7832 | 0.7114 |
MDA-MB-231 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 3327 | 3486 | 0.9544 | 0.9393 |
MDA-MB-231 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3525 | 3486 | 1.0111 | 1.0147 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 868 | 4002 | 3486 | 1.1481 | 1.1972 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2755 | 3486 | 0.7902 | 0.7207 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 868 | 928 | 3486 | 0.2662 | 0.0229 |
MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 868 | 882 | 3486 | 0.2531 | 0.0054 |
MDA-MB-231 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3092 | 3486 | 0.8869 | 0.8494 |
MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2454 | 3486 | 0.7041 | 0.6060 |
MDA-MB-231 | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2785 | 3486 | 0.7990 | 0.7324 |
MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 868 | 3640 | 3486 | 1.0442 | 1.0589 |
MDA-MB-231 | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3276 | 3486 | 0.9397 | 0.9196 |
MDA-MB-231 | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 868 | 1811 | 3486 | 0.5195 | 0.3602 |
MDA-MB-231 | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2310 | 3486 | 0.6628 | 0.5510 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 868 | 2338 | 3486 | 0.6707 | 0.5615 |